nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC5—Fluorouracil—head and neck cancer	0.535	0.675	CbGbCtD
Adefovir Dipivoxil—ABCC4—Fluorouracil—head and neck cancer	0.257	0.325	CbGbCtD
Adefovir Dipivoxil—NME1—mouth—head and neck cancer	0.00575	0.0734	CbGeAlD
Adefovir Dipivoxil—NME1—neck—head and neck cancer	0.00492	0.0627	CbGeAlD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—DPYD—head and neck cancer	0.00467	0.0613	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—hair follicle—head and neck cancer	0.00401	0.0511	CbGeAlD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00397	0.052	CbGpPWpGaD
Adefovir Dipivoxil—AK4—saliva-secreting gland—head and neck cancer	0.0037	0.0471	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—head—head and neck cancer	0.00357	0.0455	CbGeAlD
Adefovir Dipivoxil—NME1—connective tissue—head and neck cancer	0.00352	0.0449	CbGeAlD
Adefovir Dipivoxil—SLC22A3—tongue—head and neck cancer	0.00335	0.0427	CbGeAlD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—DPYD—head and neck cancer	0.00324	0.0425	CbGpPWpGaD
Adefovir Dipivoxil—NME2—epithelium—head and neck cancer	0.00315	0.0402	CbGeAlD
Adefovir Dipivoxil—AK2—thyroid gland—head and neck cancer	0.00305	0.0389	CbGeAlD
Adefovir Dipivoxil—AK4—trachea—head and neck cancer	0.00285	0.0364	CbGeAlD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00275	0.0361	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—TYMS—head and neck cancer	0.00266	0.0349	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00264	0.0346	CbGpPWpGaD
Adefovir Dipivoxil—NME1—lymphoid tissue—head and neck cancer	0.00258	0.0329	CbGeAlD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—GPX1—head and neck cancer	0.00252	0.033	CbGpPWpGaD
Adefovir Dipivoxil—NME1-NME2—lymph node—head and neck cancer	0.0025	0.0319	CbGeAlD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—DPYD—head and neck cancer	0.00245	0.0322	CbGpPWpGaD
Adefovir Dipivoxil—NME2—lymphoid tissue—head and neck cancer	0.00243	0.031	CbGeAlD
Adefovir Dipivoxil—NME1—thyroid gland—head and neck cancer	0.00234	0.0299	CbGeAlD
Adefovir Dipivoxil—AK4—thyroid gland—head and neck cancer	0.00226	0.0288	CbGeAlD
Adefovir Dipivoxil—SLC22A3—mouth—head and neck cancer	0.00225	0.0287	CbGeAlD
Adefovir Dipivoxil—NME2—thyroid gland—head and neck cancer	0.0022	0.0281	CbGeAlD
Adefovir Dipivoxil—NME1—Arf6 downstream pathway—MAPK3—head and neck cancer	0.00217	0.0285	CbGpPWpGaD
Adefovir Dipivoxil—Bone pain—Vinblastine—head and neck cancer	0.00209	0.0391	CcSEcCtD
Adefovir Dipivoxil—NME1—head—head and neck cancer	0.00208	0.0265	CbGeAlD
Adefovir Dipivoxil—NME1—Arf6 downstream pathway—MAPK1—head and neck cancer	0.00207	0.0271	CbGpPWpGaD
Adefovir Dipivoxil—AK4—head—head and neck cancer	0.002	0.0255	CbGeAlD
Adefovir Dipivoxil—NME2—head—head and neck cancer	0.00196	0.0249	CbGeAlD
Adefovir Dipivoxil—Creatinine increased—Hydroxyurea—head and neck cancer	0.00192	0.0359	CcSEcCtD
Adefovir Dipivoxil—AK2—lymph node—head and neck cancer	0.00189	0.0242	CbGeAlD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00188	0.0246	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—TYMS—head and neck cancer	0.00184	0.0242	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00183	0.024	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—CDH1—head and neck cancer	0.00175	0.023	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—GPX1—head and neck cancer	0.00175	0.0229	CbGpPWpGaD
Adefovir Dipivoxil—Foetor hepaticus—Docetaxel—head and neck cancer	0.00167	0.0313	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—parotid gland—head and neck cancer	0.00157	0.02	CbGeAlD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.0015	0.0197	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—saliva-secreting gland—head and neck cancer	0.0015	0.0191	CbGeAlD
Adefovir Dipivoxil—Hepatic failure—Hydroxyurea—head and neck cancer	0.00147	0.0276	CcSEcCtD
Adefovir Dipivoxil—NME1—lymph node—head and neck cancer	0.00145	0.0185	CbGeAlD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—CDH1—head and neck cancer	0.00142	0.0186	CbGpPWpGaD
Adefovir Dipivoxil—AK4—lymph node—head and neck cancer	0.0014	0.0179	CbGeAlD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—TYMS—head and neck cancer	0.0014	0.0183	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—head and neck cancer	0.00139	0.0183	CbGpPWpGaD
Adefovir Dipivoxil—Liver disorder—Docetaxel—head and neck cancer	0.00139	0.026	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—connective tissue—head and neck cancer	0.00138	0.0176	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—head and neck cancer	0.00137	0.0175	CbGeAlD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—GPX1—head and neck cancer	0.00132	0.0174	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—CCND1—head and neck cancer	0.00131	0.0171	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.0013	0.0171	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—thyroid gland—head and neck cancer	0.00128	0.0163	CbGeAlD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00125	0.0164	CbGpPWpGaD
Adefovir Dipivoxil—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00124	0.0232	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—UROD—head and neck cancer	0.00117	0.0153	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00114	0.0149	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Hydroxyurea—head and neck cancer	0.00112	0.021	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00104	0.0137	CbGpPWpGaD
Adefovir Dipivoxil—Pharyngitis—Vinblastine—head and neck cancer	0.000998	0.0187	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Docetaxel—head and neck cancer	0.00099	0.0185	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000966	0.0181	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Docetaxel—head and neck cancer	0.000948	0.0178	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—thyroid gland—head and neck cancer	0.000916	0.0117	CbGeAlD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—PIK3CA—head and neck cancer	0.00089	0.0117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—thyroid gland—head and neck cancer	0.000888	0.0113	CbGeAlD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—head and neck cancer	0.000814	0.0107	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—head—head and neck cancer	0.000812	0.0104	CbGeAlD
Adefovir Dipivoxil—Anaemia—Vinblastine—head and neck cancer	0.000809	0.0151	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—UROD—head and neck cancer	0.000808	0.0106	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—lymph node—head and neck cancer	0.000796	0.0101	CbGeAlD
Adefovir Dipivoxil—ABCC4—head—head and neck cancer	0.000788	0.01	CbGeAlD
Adefovir Dipivoxil—SLC22A8—head—head and neck cancer	0.000781	0.00996	CbGeAlD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFA—head and neck cancer	0.000778	0.0102	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic failure—Docetaxel—head and neck cancer	0.000766	0.0143	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Hydroxyurea—head and neck cancer	0.000738	0.0138	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—head and neck cancer	0.000727	0.00953	CbGpPWpGaD
Adefovir Dipivoxil—Renal impairment—Docetaxel—head and neck cancer	0.000723	0.0135	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Vinblastine—head and neck cancer	0.000699	0.0131	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Fluorouracil—head and neck cancer	0.00069	0.0129	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000683	0.00896	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Vinblastine—head and neck cancer	0.000681	0.0127	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000675	0.0126	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Fluorouracil—head and neck cancer	0.000655	0.0123	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—head and neck cancer	0.000654	0.00858	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000639	0.012	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000638	0.0119	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Docetaxel—head and neck cancer	0.000636	0.0119	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Hydroxyurea—head and neck cancer	0.000633	0.0118	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Hydroxyurea—head and neck cancer	0.000621	0.0116	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Vinblastine—head and neck cancer	0.000621	0.0116	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—UROD—head and neck cancer	0.000612	0.00803	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000607	0.0114	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.000606	0.00794	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000584	0.0109	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Hydroxyurea—head and neck cancer	0.000573	0.0107	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—lymph node—head and neck cancer	0.000569	0.00725	CbGeAlD
Adefovir Dipivoxil—Decreased appetite—Hydroxyurea—head and neck cancer	0.000566	0.0106	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Vinblastine—head and neck cancer	0.000565	0.0106	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000562	0.0105	CcSEcCtD
Adefovir Dipivoxil—ABCC4—lymph node—head and neck cancer	0.000551	0.00703	CbGeAlD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFA—head and neck cancer	0.000539	0.00707	CbGpPWpGaD
Adefovir Dipivoxil—Weight decreased—Docetaxel—head and neck cancer	0.000538	0.0101	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Fluorouracil—head and neck cancer	0.000531	0.00994	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Docetaxel—head and neck cancer	0.000522	0.00976	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Docetaxel—head and neck cancer	0.000517	0.00968	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Hydroxyurea—head and neck cancer	0.000515	0.00964	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Vinblastine—head and neck cancer	0.000512	0.00959	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000502	0.00939	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000498	0.00654	CbGpPWpGaD
Adefovir Dipivoxil—Myalgia—Fluorouracil—head and neck cancer	0.000489	0.00915	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Fluorouracil—head and neck cancer	0.000489	0.00915	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Vinblastine—head and neck cancer	0.000489	0.00915	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—NAT2—head and neck cancer	0.000484	0.00635	CbGpPWpGaD
Adefovir Dipivoxil—Hepatitis—Docetaxel—head and neck cancer	0.000476	0.00892	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Docetaxel—head and neck cancer	0.000473	0.00885	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Docetaxel—head and neck cancer	0.00047	0.0088	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Docetaxel—head and neck cancer	0.000468	0.00876	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Hydroxyurea—head and neck cancer	0.000467	0.00875	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Docetaxel—head and neck cancer	0.000467	0.00874	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000467	0.00612	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Fluorouracil—head and neck cancer	0.00046	0.00861	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000459	0.00859	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.000459	0.00602	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Vinblastine—head and neck cancer	0.000454	0.0085	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—GSTM1—head and neck cancer	0.000452	0.00593	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Vinblastine—head and neck cancer	0.000447	0.00837	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Fluorouracil—head and neck cancer	0.000447	0.00836	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Hydroxyurea—head and neck cancer	0.000446	0.00834	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000427	0.008	CcSEcCtD
Adefovir Dipivoxil—Nausea—Vinblastine—head and neck cancer	0.000424	0.00794	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—DPYD—head and neck cancer	0.000424	0.00557	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Docetaxel—head and neck cancer	0.000415	0.00776	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Hydroxyurea—head and neck cancer	0.000414	0.00775	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Fluorouracil—head and neck cancer	0.000413	0.00772	CcSEcCtD
Adefovir Dipivoxil—Rash—Hydroxyurea—head and neck cancer	0.000411	0.00769	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Hydroxyurea—head and neck cancer	0.00041	0.00768	CcSEcCtD
Adefovir Dipivoxil—Headache—Hydroxyurea—head and neck cancer	0.000408	0.00764	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Fluorouracil—head and neck cancer	0.000408	0.00763	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000405	0.00758	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—YAP1—head and neck cancer	0.000403	0.00528	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Docetaxel—head and neck cancer	0.000401	0.00751	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000401	0.00525	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Hydroxyurea—head and neck cancer	0.000387	0.00724	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Docetaxel—head and neck cancer	0.000383	0.00717	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00038	0.00499	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000371	0.00486	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Fluorouracil—head and neck cancer	0.000371	0.00694	CcSEcCtD
Adefovir Dipivoxil—Cough—Docetaxel—head and neck cancer	0.000362	0.00677	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Docetaxel—head and neck cancer	0.000353	0.00661	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Docetaxel—head and neck cancer	0.000353	0.00661	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000351	0.00656	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000345	0.00453	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000344	0.00451	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—NAT2—head and neck cancer	0.000335	0.0044	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Docetaxel—head and neck cancer	0.000332	0.00621	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000332	0.00435	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Fluorouracil—head and neck cancer	0.000332	0.00621	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Docetaxel—head and neck cancer	0.000331	0.0062	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—UROD—head and neck cancer	0.00033	0.00434	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Docetaxel—head and neck cancer	0.000329	0.00615	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Docetaxel—head and neck cancer	0.000323	0.00604	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Fluorouracil—head and neck cancer	0.000321	0.006	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—GSTM1—head and neck cancer	0.000313	0.00411	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000308	0.00577	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.0003	0.00393	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Fluorouracil—head and neck cancer	0.000298	0.00558	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Docetaxel—head and neck cancer	0.000298	0.00558	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000297	0.0039	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Fluorouracil—head and neck cancer	0.000296	0.00553	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Fluorouracil—head and neck cancer	0.000295	0.00553	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Docetaxel—head and neck cancer	0.000294	0.00551	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—DPYD—head and neck cancer	0.000294	0.00386	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Fluorouracil—head and neck cancer	0.000294	0.0055	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000292	0.00547	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000284	0.00372	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—YAP1—head and neck cancer	0.000279	0.00366	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Fluorouracil—head and neck cancer	0.000278	0.00521	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000277	0.00518	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.00027	0.00354	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.00027	0.00354	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000268	0.00352	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Docetaxel—head and neck cancer	0.000267	0.00501	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Docetaxel—head and neck cancer	0.000267	0.00501	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—UROD—head and neck cancer	0.000265	0.00348	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000257	0.00337	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NAT2—head and neck cancer	0.000254	0.00333	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Docetaxel—head and neck cancer	0.000243	0.00454	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—TYMS—head and neck cancer	0.000242	0.00317	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Docetaxel—head and neck cancer	0.000239	0.00448	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GSTM1—head and neck cancer	0.000239	0.00313	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000234	0.00307	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Docetaxel—head and neck cancer	0.000232	0.00433	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GPX1—head and neck cancer	0.000229	0.003	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP1A1—head and neck cancer	0.000227	0.00297	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000226	0.00297	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VEGFA—head and neck cancer	0.000225	0.00295	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000224	0.00293	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—DPYD—head and neck cancer	0.000223	0.00292	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Docetaxel—head and neck cancer	0.000215	0.00403	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000214	0.00281	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Docetaxel—head and neck cancer	0.000213	0.00399	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Docetaxel—head and neck cancer	0.000213	0.00399	CcSEcCtD
Adefovir Dipivoxil—Headache—Docetaxel—head and neck cancer	0.000212	0.00397	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—YAP1—head and neck cancer	0.000211	0.00277	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Docetaxel—head and neck cancer	0.000201	0.00376	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000191	0.00251	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—TYMS—head and neck cancer	0.000168	0.0022	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTM1—head and neck cancer	0.000166	0.00217	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GPX1—head and neck cancer	0.000159	0.00208	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP1A1—head and neck cancer	0.000157	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NAT2—head and neck cancer	0.000137	0.0018	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS2—head and neck cancer	0.000135	0.00177	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TYMS—head and neck cancer	0.000127	0.00167	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTM1—head and neck cancer	0.000126	0.00165	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—DPYD—head and neck cancer	0.00012	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GPX1—head and neck cancer	0.00012	0.00158	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP1A1—head and neck cancer	0.000119	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—head and neck cancer	0.000117	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000117	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—YAP1—head and neck cancer	0.000114	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NAT2—head and neck cancer	0.00011	0.00144	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	9.98e-05	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—DPYD—head and neck cancer	9.65e-05	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	9.44e-05	0.00124	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—head and neck cancer	9.34e-05	0.00122	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—YAP1—head and neck cancer	9.16e-05	0.0012	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	8.99e-05	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—head and neck cancer	8.29e-05	0.00109	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—head and neck cancer	8.14e-05	0.00107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	7.8e-05	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—head and neck cancer	7.08e-05	0.000928	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TYMS—head and neck cancer	6.86e-05	0.0009	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTM1—head and neck cancer	6.78e-05	0.000889	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—head and neck cancer	6.77e-05	0.000888	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GPX1—head and neck cancer	6.49e-05	0.000851	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1A1—head and neck cancer	6.43e-05	0.000843	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	6.37e-05	0.000836	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—head and neck cancer	6.17e-05	0.00081	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOTCH1—head and neck cancer	6.15e-05	0.000806	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2—head and neck cancer	6.05e-05	0.000794	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—head and neck cancer	5.74e-05	0.000754	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TYMS—head and neck cancer	5.5e-05	0.000721	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTM1—head and neck cancer	5.44e-05	0.000713	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPX1—head and neck cancer	5.21e-05	0.000683	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1A1—head and neck cancer	5.15e-05	0.000676	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—head and neck cancer	5.15e-05	0.000675	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK3—head and neck cancer	4.87e-05	0.000639	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—head and neck cancer	4.69e-05	0.000616	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK1—head and neck cancer	4.63e-05	0.000608	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—head and neck cancer	4.56e-05	0.000599	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—head and neck cancer	4.35e-05	0.000571	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—head and neck cancer	4.02e-05	0.000527	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—head and neck cancer	3.98e-05	0.000522	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—head and neck cancer	3.89e-05	0.00051	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—head and neck cancer	3.82e-05	0.000501	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—head and neck cancer	3.72e-05	0.000488	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—head and neck cancer	3.56e-05	0.000467	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—head and neck cancer	3.56e-05	0.000467	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAPK3—head and neck cancer	3.4e-05	0.000446	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—head and neck cancer	3.33e-05	0.000437	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—head and neck cancer	3.28e-05	0.000431	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAPK1—head and neck cancer	3.23e-05	0.000424	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—head and neck cancer	3.23e-05	0.000424	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—head and neck cancer	3.06e-05	0.000402	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—head and neck cancer	2.81e-05	0.000368	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—head and neck cancer	2.67e-05	0.000351	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—head and neck cancer	2.6e-05	0.000341	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—head and neck cancer	2.35e-05	0.000308	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—head and neck cancer	2.29e-05	0.000301	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—head and neck cancer	1.92e-05	0.000252	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—head and neck cancer	1.89e-05	0.000247	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—head and neck cancer	1.54e-05	0.000202	CbGpPWpGaD
